Flyonthewall.com reports a rumor of negative stent data at a conference has been making the rounds. Shares are off their highs of the day and heading back for the 200-day moving average at $17.84. Says thefly, "We are not sure if the rumors are bringing the shares in or if this is just a technical move (200-day MA has been the downtrend proxy line along with the 50-week MA which is at $18.64)."
disclosure: niether long nor short in this laggard of a stock!
No comments:
Post a Comment